Impact and cost-effectiveness of the 6-month BPaLM regimen for rifampicin-resistant tuberculosis in Moldova: A mathematical modeling analysis.

Lyndon P James Fayette Klaassen Sedona Sweeney Jennifer Furin Molly F Franke Reza YaesoubiDumitru ChesovNelly Ciobanu Alexandru Codreanu Valeriu Crudu Ted Cohen Nicolas A Menzies

Published in: PLoS medicine (2024)

Compared to standard of care, longer regimens, the implementation of the 6-month BPaLM regimen could improve the cost-effectiveness of care for individuals diagnosed with RR-TB, particularly in settings with a high burden of drug-resistant TB. Further research may be warranted to explore the impact and cost-effectiveness of shorter RR-TB regimens across settings with varied drug-resistant TB burdens and national income levels.

Keyphrases

drug resistant
mycobacterium tuberculosis
quality improvement
multidrug resistant
acinetobacter baumannii
healthcare
pulmonary tuberculosis
palliative care
primary care
physical activity
emergency department
pain management
mental health
risk factors
hiv aids
pseudomonas aeruginosa